Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

A Case Report of Pulmonary Exacerbation after Initiation of Lumacaftor/Ivacaftor Therapy in a CF Female with Complicated Lung Disease.

Hatziagorou E, Kouroukli E, Georgopoulou V, Tsanakas J.

Case Rep Pulmonol. 2018 May 30;2018:8394370. doi: 10.1155/2018/8394370. eCollection 2018.

2.

Efficacy and safety of the combination fluticasone propionate plus salmeterol in asthmatic preschoolers: An observational study.

Hatziagorou E, Kouroukli E, Galogavrou M, Papanikolaou D, Terzi DD, Anagnostopoulou P, Kirvassilis F, Panagiotakos DB, Tsanakas J.

J Asthma. 2018 Jun 29:1-8. doi: 10.1080/02770903.2018.1474923. [Epub ahead of print]

PMID:
29958011
3.

CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.

Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, Dwyer T, Petrovic M, Harris RA, Karila C, Savi D, Usemann J, Mei-Zahav M, Hatziagorou E, Ratjen F, Kriemler S; CFTR-Exercise study group.

Ann Am Thorac Soc. 2018 Feb;15(2):209-216. doi: 10.1513/AnnalsATS.201707-570OC. Epub 2017 Nov 15.

4.

Lung clearance index (LCI) as a predictor of exercise limitation among CF patients.

Avramidou V, Hatziagorou E, Kampouras A, Hebestreit H, Kourouki E, Kirvassilis F, Tsanakas J.

Pediatr Pulmonol. 2018 Jan;53(1):81-87. doi: 10.1002/ppul.23833. Epub 2017 Sep 26.

PMID:
28950435
5.

Telephone monitoring and home visits significantly improved the quality of life, treatment adherence and lung function in children with cystic fibrosis.

Chrysochoou EA, Hatziagorou E, Kirvassilis F, Tsanakas J.

Acta Paediatr. 2017 Nov;106(11):1882. doi: 10.1111/apa.13996. Epub 2017 Aug 13. No abstract available.

PMID:
28727186
6.

A "real-life" study on height in prepubertal asthmatic children receiving inhaled steroids.

Hatziagorou E, Kouroukli E, Avramidou V, Papagianni M, Papanikolaou D, Terzi D, Karailidou M, Kirvassilis F, Panagiotakos D, Tsanakas J.

J Asthma. 2018 Apr;55(4):437-442. doi: 10.1080/02770903.2017.1336243. Epub 2017 Jul 31.

PMID:
28708950
7.

Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis.

Kaditis AG, Miligkos M, Bossi A, Colombo C, Hatziagorou E, Kashirskaya N, de Monestrol I, Thomas M, Mei-Zahav M, Chrousos G, Zolin A.

Arch Dis Child. 2017 Aug;102(8):742-747. doi: 10.1136/archdischild-2016-311132. Epub 2017 Mar 21.

PMID:
28325727
8.

Home intravenous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit.

Chrysochoou EA, Hatziagorou E, Kirvassilis F, Tsanakas J.

Hippokratia. 2016 Oct-Dec;20(4):279-283.

9.

Exercise responses are related to structural lung damage in CF pulmonary disease.

Hatziagorou E, Kampouras A, Avramidou V, Georgopoulou V, Kirvasilis F, Kontouli K, Hebestreit H, Tsanakas J.

Pediatr Pulmonol. 2016 Sep;51(9):914-20. doi: 10.1002/ppul.23474. Epub 2016 May 12.

PMID:
27171573
10.

Pancreatic Cystosis in Two Adolescents with Cystic Fibrosis.

Hatziagorou E, Kampouras A, Sidiropoulou M, Markou A, Anastasiou A, Tsanakas J.

Case Rep Pediatr. 2016;2016:5321785. doi: 10.1155/2016/5321785. Epub 2016 Mar 24.

11.

Validation study of the pediatric allergic rhinitis quality of life questionnaire.

Mavroudi A, Chrysochoou EA, Boyle RJ, Papastergiopulos A, Karantaglis N, Karagiannidou A, Xinias I, Farmaki E, Hatziagorou E, Kirvassilis F, Kourentas G, Tsanakas J, Warner JO.

Asian Pac J Allergy Immunol. 2016 Jun;34(2):159-65. doi: 10.12932/AP0651.34.2.2016.

12.

Use of lung clearance index to assess the response to intravenous treatment in cystic fibrosis.

Hatziagorou E, Avramidou V, Kirvassilis F, Tsanakas J.

Hippokratia. 2015 Jan-Mar;19(1):47-52.

13.

Antioxidant foods consumption and childhood asthma and other allergic diseases: The Greek cohorts of the ISAAC II survey.

Papadopoulou A, Panagiotakos DB, Hatziagorou E, Antonogeorgos G, Matziou VN, Tsanakas JN, Gratziou C, Tsabouri S, Priftis KN.

Allergol Immunopathol (Madr). 2015 Jul-Aug;43(4):353-60. doi: 10.1016/j.aller.2014.03.002. Epub 2014 Aug 3.

PMID:
25097022
14.

Long-term outcome of parapneumonic effusions in children: Lung function and exercise tolerance.

Kontouli K, Hatziagorou E, Kyrvasilis F, Roilides E, Emporiadou M, Tsanakas J.

Pediatr Pulmonol. 2015 Jun;50(6):615-20. doi: 10.1002/ppul.23054. Epub 2014 Apr 29.

PMID:
24777950
15.

Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.

Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, Drevinek P, Gulmans V, Krivec U, Olesen H; ECFS Patient Registry Steering Group.

Eur Respir J. 2014 Jan;43(1):125-33. doi: 10.1183/09031936.00166412. Epub 2013 Apr 18.

16.

Determinants of quality of life in children with asthma.

Petsios KT, Priftis KN, Hatziagorou E, Tsanakas JN, Antonogeorgos G, Matziou VN.

Pediatr Pulmonol. 2013 Dec;48(12):1171-80. doi: 10.1002/ppul.22768. Epub 2013 Feb 8.

PMID:
23401462
17.

Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case.

Katragkou A, Antachopoulos C, Hatziagorou E, Sdougka M, Roilides E, Tsanakas J.

Eur J Pediatr. 2013 Apr;172(4):563-7. doi: 10.1007/s00431-012-1811-8. Epub 2012 Aug 21.

PMID:
22907397
18.

Level of parent-asthmatic child agreement on health-related quality of life.

Petsios K, Priftis KN, Tsoumakas C, Hatziagorou E, Tsanakas JN, Galanis P, Antonogeorgos G, Matziou V.

J Asthma. 2011 Apr;48(3):286-97. doi: 10.3109/02770903.2011.555031.

PMID:
21391881
19.

Comparison in asthma and allergy prevalence in the two major cities in Greece: the ISAAC phase II survey.

Papadopoulou A, Hatziagorou E, Matziou VN, Grigoropoulou DD, Panagiotakos DB, Tsanakas JN, Gratziou C, Priftis KN.

Allergol Immunopathol (Madr). 2011 Nov-Dec;39(6):347-55. doi: 10.1016/j.aller.2010.10.003. Epub 2011 Feb 20.

PMID:
21342745
20.

Acute respiratory admissions in Thessaloniki, Greece: 14-year follow-up.

Hatziagorou E, Kirvassilis F, Saraphidou S, Katsara M, Valeri R, Emporiadou M, Magnisali C, Tsanakas J.

Hippokratia. 2009 Oct;13(4):242-6.

21.

Aspergillus and the paediatric lung.

Hatziagorou E, Walsh TJ, Tsanakas JN, Roilides E.

Paediatr Respir Rev. 2009 Dec;10(4):178-85. doi: 10.1016/j.prrv.2009.06.006. Epub 2009 Sep 26. Review.

PMID:
19879507
22.

Cough affects quality of life in asthmatic children aged 8-14 more than other asthma symptoms.

Petsios KT, Priftis KN, Tsoumakas C, Perperoglou A, Hatziagorou E, Tsanakas JN, Androulakis I, Matziou VN.

Allergol Immunopathol (Madr). 2009 Mar-Apr;37(2):80-8.

PMID:
19445864
23.

High resolution computed tomography of the chest in cystic fibrosis (CF): is simplification of scoring systems feasible?

Oikonomou A, Tsanakas J, Hatziagorou E, Kirvassilis F, Efremidis S, Prassopoulos P.

Eur Radiol. 2008 Mar;18(3):538-47. Epub 2007 Nov 27.

PMID:
18040691
24.

Assessment of airway inflammation with exhaled NO measurement.

Hatziagorou E, Tsanakas J.

Hippokratia. 2007 Apr;11(2):51-62.

Supplemental Content

Loading ...
Support Center